Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,521.24
(
0.42%
)
News Focus
News Focus
Post# of 80490
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: adreamer post# 14213

Wednesday, 11/16/2011 10:12:37 AM

Wednesday, November 16, 2011 10:12:37 AM

Post# of 80490

what's baked in to the current market cap



Ponatinib approval for 3rd-line. 80% chance of rida approval. Nothing for '113 or rida combination therapy.

In terms of near-term catalysts there is the updated data at ASH (unlikely to move the stock much either way) and maybe an Asia partnership.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today